{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:24:35Z","timestamp":1787862275394,"version":"build-2784847793"},"reference-count":35,"publisher":"American Society of Clinical Oncology (ASCO)","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["J Clin Oncol"],"DOI":"10.1200\/jco-26-01480","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:59:21Z","timestamp":1787860761000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Speeding to a Stop: Postapproval Barriers to Accessing New Lung Cancer Therapies"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0781-9257","authenticated-orcid":false,"given":"Ibiayi","family":"Dagogo-Jack","sequence":"first","affiliation":[{"name":"Mass General Brigham Cancer Institute, Boston, MA"},{"name":"Department of Medicine, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.06.028"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35770"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/OP-24-00936"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00120"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7305"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21443"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.4865"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.21575"},{"key":"e_1_3_3_11_2","first-page":"137","article-title":"Financial toxicity among people with metastatic cancer: Findings from the Cancer Experience Registry","volume":"32","author":"Mollica MA","year":"2024","unstructured":"Mollica MA, Zaleta AK, Gallicchio L, et al: Financial toxicity among people with metastatic cancer: Findings from the Cancer Experience Registry. Support Care Cancer 32:137, 2024","journal-title":"Support Care Cancer"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.017509"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.027896"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00948-1"},{"key":"e_1_3_3_15_2","first-page":"qxad030","article-title":"Commercial coverage of specialty drugs, 2017-2021","volume":"1","author":"Rucker JA","year":"2023","unstructured":"Rucker JA, Beinfeld MT, Jenkins NB, et al: Commercial coverage of specialty drugs, 2017-2021. Health Aff Sch 1:qxad030, 2023","journal-title":"Health Aff Sch"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.15148"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_100036"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.15445"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4488"},{"key":"e_1_3_3_20_2","volume-title":"U.S. Medical Centers Need a New Model for Drug Discovery and Development","author":"Offodile AC","year":"2026","unstructured":"Offodile AC, Kadakia KT, Dash Y, et al: U.S. Medical Centers Need a New Model for Drug Discovery and Development. Harvard Business Review, 2026"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.104086"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00788"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","unstructured":"Zhou C Greillier L Liu G et al: First-line sunvozertinib in NSCLC with. N Engl J Med 10.1056\/NEJMoa2604461 [epub ahead of print on May 29 2026]","DOI":"10.1056\/NEJMoa2604461"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","unstructured":"Zhou K Ebben L Dhakal B et al: Implementation of bispecific antibodies in the community: Lessons from the ThedaCare cancer Center experience. JCO Oncol Pract 10.1200\/OP-25-00748 [epub ahead of print on January 13 2026]","DOI":"10.1200\/OP-25-00748"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307980"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35738"},{"key":"e_1_3_3_27_2","volume-title":"Access and Reimbursement","author":"Imdelltra","unstructured":"Imdelltra: Access and Reimbursement. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK613789\/"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2026.03.337"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2026.109390"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108870"},{"key":"e_1_3_3_31_2","volume-title":"Canadian Agency for Drugs and Technologies in Health","author":"Tarlatamab (Imdelltra)","year":"2025","unstructured":"Tarlatamab (Imdelltra): Indication: The treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after at least 2 prior lines of therapy including platinum-based chemotherapy: Reimbursement Recommendation. Ottawa, ON, Canadian Agency for Drugs and Technologies in Health, 2025"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104538"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.1652"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01001"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.05.005"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2025.100625"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO-26-01480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:59:22Z","timestamp":1787860762000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO-26-01480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":35,"alternative-id":["10.1200\/JCO-26-01480"],"URL":"https:\/\/doi.org\/10.1200\/jco-26-01480","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"2026-06-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"JCO-26-01480"}}